-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Duffy-null Associated Neutrophil Counts--What is Normal

Program: Spotlight Sessions
Session: What is a “Normal” Neutrophil Count? The Duffy Red Cell Antigen, Ancestry, Genetics and Evolution
Hematology Disease Topics & Pathways:
Clinical Practice (Health Services and Quality), Diversity, Equity, and Inclusion (DEI)
Monday, December 11, 2023, 2:45 PM-4:00 PM

Lauren E. Merz, MD, MSc

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Mass General Brigham, Boston

Disclosures: Merz: X4 Pharmaceuticals: Honoraria; Alexion Pharmaceuticals: Consultancy, Research Funding.

Previous Presentation | Next Presentation >>